Loading…
Beyond Air, Inc. is projected to decline to $0.3777 by 2027, a -9% move from its current price of $0.417. XAIR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.3984 | $0.4165 | $0.4354 | -0.12% |
| Jul 14 | $0.3907 | $0.416 | $0.443 | -0.23% |
| Jul 15 | $0.3848 | $0.4156 | $0.4487 | -0.35% |
| Jul 16 | $0.3798 | $0.4151 | $0.4536 | -0.46% |
| Jul 17 | $0.3755 | $0.4146 | $0.4578 | -0.58% |
| Jul 18 | $0.3715 | $0.4141 | $0.4616 | -0.69% |
| Jul 19 | $0.3678 | $0.4136 | $0.4651 | -0.81% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.3678 | $0.4136 | $0.4651 | -0.81% |
| Week 2 | $0.3476 | $0.4103 | $0.4844 | -1.60% |
| Week 3 | $0.3321 | $0.407 | $0.4987 | -2.40% |
| Week 4 | $0.3193 | $0.4037 | $0.5105 | -3.18% |
| Week 5 | $0.308 | $0.4005 | $0.5207 | -3.96% |
| Week 6 | $0.298 | $0.3973 | $0.5296 | -4.74% |
| Week 7 | $0.2889 | $0.3941 | $0.5375 | -5.50% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments.
The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO to treat viral lung infections, such as viral community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM). In addition, the company develops ultra-high concentration NO (UNO) that is in Phase 1 clinical trial to treat solid tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions.
It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc.
in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.
Beyond Air, Inc. is a Healthcare stock trading as XAIR. The current price is $0.4275 and the market cap is $6.16M, with a rank of 5264. The stock sits in the Healthcare sector and operates as a commercial-stage medical device and biopharmaceutical company.
The 30-day technical picture shows a neutral stance, with a relative strength index of 50, and moving averages at $0.4556 (SMA50) and $1.10 (SMA200). The 30-day range runs from $0.3165 to $0.5774, with nearby support at $0.346 and resistance at $0.495.
The forecast paints a mixed near-term path and a longer-term upside, with neutral in 2026 and 2030, bearish in 2027-2029, and bullish in 2040 and 2050. The average forecast prices over select years include 2026 $0.4275, 2027 $0.3886, 2028 $0.3448, 2029 $0.33, 2030 $0.4361, 2040 $0.6381, and 2050 $1.17, with corresponding max prices up to $1.30 in 2040 and $2.69 in 2050.
A major floor 35.2% below — a decisive break under it would weaken the trend.
The nearest floor, 17.0% below — buyers have tended to step in here.
The nearest ceiling, 18.7% above — a clean break opens room to run.
A major ceiling 107.9% above — clearing it would confirm fresh momentum.
Key XAIR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of XAIR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.4328 | Sell | $0.4327 | Sell |
| MA 10 | $0.4505 | Sell | $0.4383 | Sell |
| MA 20 | $0.4265 | Sell | $0.4382 | Sell |
| MA 50 | $0.4538 | Sell | $0.4839 | Sell |
| MA 100 | $0.6078 | Sell | $0.6699 | Sell |
| MA 200 | $1.09 | Sell | $1.51 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.18 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -15.97 | Neutral |
| Williams %R (14) | -90.70 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -10.90 | Sell |
| Bollinger %B (20,2) | 0.45 | Neutral |
| Stochastic %K (14) | 9.30 | Buy |
| TRIX (15) | -0.07 | Sell |
| Awesome (5,34) | 0.01 | Buy |
| Ultimate (7,14,28) | 41.67 | Neutral |
| Momentum (10) | -0.06 | Sell |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 0.42 | Sell |
| ADX (14) | 14.32 | Neutral |
| ATR (14) | 0.02 | Info |
The market mood is NEUTRAL, and the RSI14 sits at 50. The price is trading below the 50-day simple moving average of $0.4556 and well below the 200-day moving average of $1.10. This suggests a cautious stance in the near term.
The 30-day range runs from $0.3165 to $0.5774, with near-term support at $0.346 and resistance at $0.495. Investors may watch how the price behaves around these levels as the stock traverses its current technical backdrop.
Current price: $0.4275. Market cap: $6.16M. Rank: 5264. The 50-day and 200-day moving averages lie above and beyond the current price, indicating mixed momentum in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.346 | $0.417 | $0.4918 | 0% | Neutral | |
| $0.2832 | $0.3777 | $0.5418 | -9% | Neutral | |
| $0.2386 | $0.3341 | $0.5064 | -20% | Bearish | |
| $0.2193 | $0.3199 | $0.5059 | -23% | Bearish | |
| $0.2797 | $0.4233 | $0.6935 | +2% | Neutral | |
| $0.3122 | $0.4889 | $0.8257 | +17% | Neutral | |
| $0.2996 | $0.4846 | $0.841 | +16% | Neutral | |
| $0.2601 | $0.4338 | $0.7713 | +4% | Neutral | |
| $0.2475 | $0.4252 | $0.7731 | +2% | Neutral | |
| $0.2527 | $0.4468 | $0.8292 | +7% | Neutral | |
| $0.3067 | $0.6213 | $1.26 | +49% | Bullish | |
| $0.514 | $1.14 | $2.60 | +174% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.346 | $0.417 | $0.5118 | +0.00% |
| August 2026 | $0.3368 | $0.4045 | $0.5036 | -3.00% |
| September 2026 | $0.309 | $0.3753 | $0.4755 | -7.21% |
| October 2026 | $0.3072 | $0.3769 | $0.4845 | +0.42% |
| November 2026 | $0.3135 | $0.388 | $0.5048 | +2.94% |
| December 2026 | $0.2997 | $0.3738 | $0.4918 | -3.66% |
Click any year to see its month-by-month XAIR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, XAIR could reach as high as $0.4918, with a base case around $0.417 and support toward $0.346 — roughly 0% from $0.417. A consolidation phase looks the most probable path here.
Expect XAIR to range from $0.2832 to $0.5418 through 2027. The $0.3777 average target implies a -9% move from current prices. That is -9% versus the projected 2026 average. Price action looks broadly range-bound.
The XAIR price prediction for 2028 points to an average of $0.3341 (low $0.2386, high $0.5064) — a potential decline of -20% on today's $0.417. Expect choppier, lower action through this leg of the cycle.
In 2029, XAIR is projected to trade between $0.2193 and $0.5059, averaging $0.3199 — a potential decline of -23% from today's $0.417. That is -4% versus the projected 2028 average. A cyclical pullback looks likely — prices rarely move in a straight line.
Beyond Air, Inc.'s 2030 outlook centres on $0.4233, within a $0.2797 to $0.6935 range. That is up +32% on the projected 2029 average. That marks a +2% change versus current levels. A consolidation phase looks the most probable path here.
By 2031, XAIR could reach as high as $0.8257, with a base case around $0.4889 and support toward $0.3122 — roughly +17% from $0.417. Price action looks broadly range-bound.
Expect XAIR to range from $0.2996 to $0.841 through 2032. The $0.4846 average target implies a +16% move from current prices. That is -1% versus the projected 2031 average. A consolidation phase looks the most probable path here.
The XAIR price prediction for 2033 points to an average of $0.4338 (low $0.2601, high $0.7713) — a potential gain of +4% on today's $0.417. Price action looks broadly range-bound.
In 2034, XAIR is projected to trade between $0.2475 and $0.7731, averaging $0.4252 — a potential gain of +2% from today's $0.417. That is -2% versus the projected 2033 average. A consolidation phase looks the most probable path here.
Beyond Air, Inc.'s 2035 outlook centres on $0.4468, within a $0.2527 to $0.8292 range. That is up +5% on the projected 2034 average. That marks a +7% change versus current levels. Price action looks broadly range-bound.
By 2040, XAIR could reach as high as $1.26, with a base case around $0.6213 and support toward $0.3067 — roughly +49% from $0.417. Buyers look set to stay in control over this stretch.
Expect XAIR to range from $0.514 to $2.60 through 2050. The $1.14 average target implies a +174% move from current prices. That is up +84% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in XAIR today (≈ 2,398.081535 XAIR) could be worth
$2,739.16
+$1,739.16 (+174%) by 2050 · US Dollar
Based on the average projected XAIR price of $1.14 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in XAIRwould be worth at today's price.
$1,000 invested in XAIR on Jul 10, 2025 (≈ 256.41025 XAIR) would be worth
$106.92
-$893.08 (-89.3%) today · 0.11× · US Dollar
Based on a XAIR entry price of $3.9 vs. today's $0.417.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.468 | $891.03 | -10.9% |
| 1 month ago | $0.38 | $1,097.37 | +9.7% |
| 3 months ago | $0.788 | $529.19 | -47.1% |
| 6 months ago | $0.876 | $476.03 | -52.4% |
| 1 year ago | $3.9 | $106.92 | -89.3% |
| All time (5.0y) ago | $135.4 | $3.08 | -99.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our XAIR forecast.
Our base-case forecast reaches $0.83 around 2050.
Implied market cap at $0.83: $598.04K
The year-by-year forecast depicts a path from neutral to bullish over the long horizon. For 2026 the avg price is $0.4275 with min $0.346 and max $0.5066 (ROI 0). In 2027 the avg is $0.3886 with min $0.2901 and max $0.5606 (ROI -9.1).
In 2028 the avg is $0.3448 (min $0.2447, max $0.5261, ROI -19.4), and in 2029 the avg is $0.33 (min $0.2245, max $0.5259, ROI -22.8).
In 2030 the avg climbs to $0.4361 (min $0.2856, max $0.7203, ROI 2). The path continues with 2031 avg $0.5012 (min $0.3168, max $0.8541, ROI 17.3) and 2032 avg $0.4958 (min $0.303, max $0.8684, ROI 16), followed by 2033 avg $0.4473 (min $0.2648, max $0.8032, ROI 4.6), 2034 avg $0.4387 (min $0.2518, max $0.8057, ROI 2.6), and 2035 avg $0.4596 (min $0.256, max $0.862, ROI 7.5).
The forecast turns bullish by 2040, with avg $0.6381, min $0.3083, max $1.30 (ROI 49.3). By 2050 the avg is $1.17, min $0.5271, max $2.69 (ROI 174), indicating meaningful upside potential over the longer horizon.
Tap a question to reveal the answer.
Avg price $0.4361; min $0.2856; max $0.7203; ROI 2; sentiment NEUTRAL.
The forecast shows mixed near-term performance with NEUTRAL in 2026 and 2030, but bullish potential in 2040 (avg $0.6381, max $1.30, ROI 49.3) and 2050 (avg $1.17, max $2.69, ROI 174). These are estimates and not guarantees.
Yes. The forecast maximum price by 2040 is $1.30.
Current price is $0.4275.
Market cap is $6.16M.
Beyond Air, Inc. Community Discussion
0Share your Beyond Air, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.